Literature DB >> 17926618

[Eye acupuncture for treatment of renal and ureteral colic].

Qiang Lin1, Yu-lian Hu, Chong-wei Han, Yan Li.   

Abstract

OBJECTIVE: To observe the therapeutic effect of eye acupuncture on renal and ureteral colic induced by ureterolith.
METHODS: One hundred and eighty cases were randomly divided into an eye acupuncture group (n=90), a Morphine group (n=40) and a Bucinnazine group (n=50). The eye acupuncture group were treated with acupuncture at eye acupoints for killing pain, the Morphine group with intramuscular injection of Morphine and Atropine, and the Bucinnazine group with intramuscular injection of Bucinnazine and Atropine.
RESULTS: The markedly effective rate and the total effective rate were 72.2% and 95.6% in the eye acupuncture group, 45.0% and 77.5% in the Morphine group and 42.0% and 72.0% in the Bucinnazine group. Both the markedly effective rate and the total effective rate in the eye acupuncture group were significantly higher than those in both the Morphine group and the Bucinnazine group (all P < 0.01).
CONCLUSION: Eye acupuncture therapy is rapid and effective for treatment of renal and ureteral colic induced by ureterolith.

Entities:  

Mesh:

Year:  2007        PMID: 17926618

Source DB:  PubMed          Journal:  Zhongguo Zhen Jiu        ISSN: 0255-2930


  2 in total

Review 1.  Visceral pain originating from the upper urinary tract.

Authors:  Katja Venborg Pedersen; Asbjørn Mohr Drewes; Poul Christian Frimodt-Møller; Palle Jørn Sloth Osther
Journal:  Urol Res       Date:  2010-05-16

2.  Dermal scarification versus intramuscular diclofenac sodium injection for the treatment of renal colic: a prospective randomized clinical trial.

Authors:  Stavros Ioannidis; Spyridon Kampantais; Anastasios Ioannidis; Konstantinos Gkagkalidis; Ioannis Vakalopoulos; Chrysovalantis Toutziaris; Christos Patsialas; Leonidas Laskaridis; Panagiotis Dimopoulos; Georgios Dimitriadis
Journal:  Urolithiasis       Date:  2014-07-30       Impact factor: 3.436

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.